Molecular Templates, Inc. (MTEM) Social Stream



Molecular Templates, Inc. (MTEM): $0.58

0.04 (+7.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MOLECULAR TEMPLATES INC (MTEM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MTEM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 6 $18 $12 $13.6 $0.535 2442.06%
2021-12-02 6 $14 $9 $11.75 $0.535 2096.26%
2022-03-09 5 $14 $9 $11.75 $0.535 2096.26%
2022-03-28 4 $14 $9 $11.5 $0.535 2049.53%
2022-03-30 5 $14 $4.5 $9.9 $0.535 1750.47%
2022-05-12 5 $14 $4.5 $9.5 $0.535 1675.7%
2022-05-13 5 $14 $4.5 $9.1 $0.535 1600.93%
2022-07-18 5 $14 $1.5 $7.6 $0.535 1320.56%
2022-08-11 5 $12 $1.5 $7.2 $0.535 1245.79%
2022-09-17 5 $12 $1.5 $6.4 $0.535 1096.26%
2023-01-26 5 $12 $1 $5.875 $0.535 998.13%

The Trend in the Analyst Price Target


Over the past 23 months, MTEM's average price target has gone down $13.38.

MTEM reports an average of 582.8% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-09 4 14 9.0 11.750 2.550 360.78%
2022-03-09 5 14 9.0 11.750 2.550 360.78%
2022-05-13 5 14 4.5 9.100 1.240 633.87%
2022-07-18 5 14 1.5 7.600 1.000 660%
2023-01-26 5 12 1.0 5.875 0.528 1012.69%

MTEM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 4 0 0 0 0 5

The Trend in the Broker Recommendations


MTEM's average broker recommendation rating worsened by 0.6 over the prior 35 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, MOLECULAR TEMPLATES INC's upside potential (average analyst target price relative to current price) is higher than 1476.95% of them.
  • In terms of how MOLECULAR TEMPLATES INC fares relative to all US stocks, note that its average analyst price target is higher than 153.58% of that group.
  • MTEM has a lower variance in analysts' estimates than -771.25% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, MOLECULAR TEMPLATES INC's number of analysts covering the stock is higher than 469.68% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MOLECULAR TEMPLATES INC are SVRA, BPTH, and GALT.

Make investment decisions regarding MTEM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7328 seconds.